Monday, April 19, 2021
Home Life Style Health & Fitness This New Injectable Drug Can Block HIV From Entering Cells

This New Injectable Drug Can Block HIV From Entering Cells

Scientists have developed an injectable HIV drug with fewer side effects

Researchers have developed an injectable new drug that blocks HIV from entering cells which offers long-lasting protection from the infection with fewer side effects.

The drug, which was tested in non-human primates, could eventually replace or supplement components of combination drug “cocktail” therapies currently used to prevent or treat the virus.

“This is an exciting new HIV therapeutic option for both prevention and treatment, with a unique mechanism of action compared to other approved drugs,” said study author Michael S. Kay from the University of Utah in the US.

Follow NewsGram on LinkedIn to know what’s happening around the world.

“It has great potential to help patients who suffer from drug resistance as well as those who would benefit from a longer-acting, injectable anti-HIV drug cocktail,” Kay added.

Scientists develop injectable HIV drug with fewer side effects
D-peptides are mirror images of naturally occurring peptides. Wikimedia Commons

In this new study, published in the journal Proceedings of the National Academy of Sciences (PNAS), the researchers tested a unique drug called CPT31, based on a D-peptide that targets a critical pocket on HIV’s fusion machinery that rarely mutates.

D-peptides are mirror images of naturally occurring peptides.

“To imagine it, think of right and left hands. The building blocks and overall structure of natural peptides are analogous to our left hand versus our right hand for D-peptides,” the researchers said.

Because of that, CPT31 and other D-peptides are not degraded in the body. Therefore, they last much longer than natural peptides, making them especially suitable for a long-acting injectable formulation.

To see if CPT31 could prevent HIV infection, the research team first injected the drug into healthy macaque monkeys starting several days prior to exposure to a hybrid simian-human form of HIV called SHIV.

The monkeys were completely protected from this very high SHIV exposure, much higher than what humans typically encounter, and never developed signs of infection.

Subsequently, the scientists identified the minimum dose of CPT31 needed to confer complete protection, information that will help inform clinical trials.

“We think this drug could be used by itself to prevent HIV infection because initial HIV exposure typically involves a relatively small amount of virus,” Kay said.

Scientists develop injectable HIV drug with fewer side effects
To see if CPT31 could prevent HIV infection, the research team first injected the drug into healthy macaque monkeys. Pixabay

This study showed that the vast majority of circulating HIV strains from around the world are potently blocked by CPT31.

“But what about later stages of the disease when there are billions of copies of the virus circulating in the body?” the team asked.

Also Read: Google Announces These Exciting New Features for its Pixel Buds

To find out, the researchers gave CPT31 to monkeys with untreated SHIV infections and high viral loads. Over the course of 30 days, the drug significantly lowered the presence of SHIV in their bloodstreams.

In this study, CPT31 by itself effectively kept the virus at an undetectable level for months (until drug administration was discontinued).

“Upcoming human trials, scheduled for later this year, will help determine whether CPT31 is safe and effective in humans,” the team noted. (IANS)

STAY CONNECTED

19,517FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

‘Child Of Two Worlds’ Featuring The Protagonists And Immortal Lovers

Turkey-based author Ann D'Silva has launched her new book "Child of Two Worlds", which is second in the fictional 'Sand and Sea' series, which...

Now Transfer Posts And Notes To Google Docs And WordPress Directly

Facebook on Monday introducing two new data portability types that will help users directly transfer their posts and notes to Google Documents, Blogger, and...

Lyricist Mehboob: The Line Between Film Music And Indie Music Has Blurred Lately

The line between film music and indie music has blurred lately, feels noted lyricist Mehboob, who has over 25 years of experience in the...

OTT Projects Based On Books

With OTT platforms experimenting with genres and content, there are a host of projects that are based on books. Lately, we have already had...

Something Screened On Your Phone Can Not Erase A Huge Screen, Says Boman Irani

Good writing is the need of the hour, feels actor Boman Irani, to sustain audience interest at a time when OTT provides a surfeit...

The Truth Behind Why Airliners Don’t Fly Over Tibet

BY- JAYA CHOUDHARY Airplanes can fly for thousands of kilometers across the globe. Rockets have landed men on the moon and Elon Musk plans to...

Symptoms Affecting Daily Life Post Covid Recovery

Are you a Covid-19 survivor, but still feel fatigued and not having fully recovered? You may be experiencing what is known as "Long Covid"....

Study Highlights How An Asthma Drug Can Speed Up Recovery From Covid-19

Inhaled budesonide -- primarily an asthma drug -- can shorten recovery time among Covid patients aged over 50, according to a study. Early treatment...

Recent Comments